Treatment with valsartan stimulates endothelial progenitor cells and renal label-retaining cells in hypertensive rats

Journal of Hypertension

Volumn 29, Issue 1, 2011, Pages 91-101

  Yoshida, Yoshinori ^a   Fukuda, Noboru ^a,b   Maeshima, Akito ^c   Yamamoto, Chii ^b   Matsumoto, Taro ^a   Ueno, Takahiro ^a   Nojima, Yoshihisa ^c   Matsumoto, Koichi ^a   Soma, Masayoshi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

angiotensin II receptor blocker; endothelial progenitor cell; label retaining cell; renal stem cell; stroke prone spontaneously hypertensive rat

Indexed keywords

ANGIOTENSIN II; BROXURIDINE; HYDRALAZINE; STEM CELL FACTOR; TRANSCRIPTION FACTOR PAX2; VALSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CELL MIGRATION; CELL STIMULATION; COLONY FORMATION; DRUG EFFECT; ENDOTHELIAL PROGENITOR CELL; HYPERTENSION; KIDNEY CELL; KIDNEY MEDULLA; KIDNEY TUBULE DEGENERATION; KIDNEY TUBULE DISORDER; MALE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL LABEL RETAINING CELL; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 78650810277     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834000e2     Document Type: Article

References (41)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Marshall VS. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145-1147.
2. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000; 100:157-168.
3. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114:763-776.
4. Al-Awqati Q, Oliver JA. Stem cells in the kidney. Kidney Int 2002; 61:387-395.
5. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275:964-967.
6. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348:593-600.
7. Dernbach E, Urbich C, Brandes RP, Hofmann WK, Zeiher AM, Dimmeler S. Effects of establishing cell cultures and cell culture conditions on the proliferative life span of human fibroblasts isolated from different tissues and donors of different ages. Exp Cell Res 2002; 274:275-287.
8. Dernbach E, Urbich C, Brandes RP, Hofmann WK, Zeiher AM, Dimmeler S. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 2004; 104:3591-3597.
9. Sanada S, Kitakaze M, Node K, Takashima S, Ogai A, Asanuma H, et al. Differential subcellular actions of ACE inhibitors and AT[1] receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats. Hypertension 2001; 38:404-411.
10. Fukuda N,SatohC,HuW-Y, Soma M,Kubo A, Kishioka H, et al. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1999; 19:1210-1217.
11. Wassmann S, Nickenig G. Pathophysiological regulation of the AT1-receptor and implications for vascular disease. J Hypertens Suppl 2006; 24:S15-S21.
12. Rueckschloss U, Quinn MT, Hotz J, Morawietz H. Dose-dependent regulation of NAD[P]H oxidase expression by angiotensin II in human endothelial cells. Protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2002; 22:1845-1851.
13. Moriki N, Ito M, Seko T, Kureishi Y, Okamoto R, Nakakuki T, et al. RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertens Res 2004; 27:263-270.
14. Negishi H, Ikeda K, Sagara M, Sawamura M, Yamori Y. Increased oxidative DNA damage in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1999; 26:482-484. (Pubitemid 29306970)
15. Lee MC, Shoji H, Miyazaki H, Yoshino F, Hori N, Toyoda M, et al. Assessment of oxidative stress in the spontaneously hypertensive rat brain using electron spin resonance (ESR) imaging and in vivo L-Band ESR. Hypertens Res 2004; 27:485-492.
16. Yao E-H, Fukuda N, Matsumoto T, Katakawa M, Yamamoto C, Tsunemi A, et al. Losartan improves formation and function of endothelial progenitor cells in hypertension via an antioxidant effect. Hypertens Res 2007; 30:1119-1128.
17. Yu Y, Fukuda N, Yao E-H, Matsumoto T, Kobayashi N, Suzuki R, et al. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension. Am J Hypertens 2008; 21:72-77.
18. Maeshima A, Yamashita S, Nojima Y. Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney. J Am Soc Nephrol 2003; 14:3138-3146.
19. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003; 107:1322-1328.
20. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18:3964-3972. (Pubitemid 29335849)
21. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, et al. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 2003; 14:2775-2782.
22. Ono H, Ono Y. Nephrosclerosis and hypertension. Med Clin North Am 1997; 81:1273-1288.
23. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol 2002; 13:2860-2868.
24. Nyby MD, Abedi K, Smutko V, Eslami P, Tuck ML. Vascular Angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats. Hypertens Res 2007; 30:451-457.
25. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003; 42:1075-1081.
26. Oliver JA,MaaroufO,CheemaFH,MartensTP,Al-AwqatiQ.Therenalpapilla is a niche for adult kidney stem cells. J Clin Invest 2004; 114: 795-804.
27. Yamashita S, Maeshima A, Nojima Y. Involvement of renal progenitor tubular cells in epithelial-to-mesenchymal transition in fibrotic rat kidneys. J Am Soc Nephrol 2005; 16:2044-2051.
28. Fujigaki Y, Goto T, Sakakima M, Fukasawa H, Miyaji T, Yamamoto T, Hishida A. Kinetics and characterization of initially regenerating proximal tubules in S3 segment in response to various degrees of acute tubular injury. Nephrol Dial Transplant 2006; 21:41-50.
29. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59:251-287.
30. Gore-Hyer E, Shegogue D, Markiewicz M, Lo S, Hazen-Martin D, Greene EL, et al. TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol 2002; 283:F707-F716.
31. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9:964-968.
32. Matsumoto K, Morishita R, Moriguchi A, Tomita N, Yo Y, Nishii T, et al. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats. Hypertension 1999; 34:279-284.
33. Song JH, Cha SH, Hong SB, Kim DH. Dual blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease. J Hypertens Suppl 2006; 24:S101-S106.
34. Tahira Y, Fukuda N, Endo M, Suzuki R, Ikeda Y, Takagi H, Kanmatsuse K. Transforming growth factor-beta expression in cardiovascular organs in stroke-prone spontaneously hypertensive rats with the development of hypertension. Hypertens Res 2002; 25:911-918.
35. Tahira Y, Fukuda N, Endo M, Suzuki R, Takagi H, Ikeda Y, et al. Chimeric DNA-RNA hammerhead ribozyme targeting TGF-b1 mRNA efficiently ameliorated renal injury in hypertensive rats. J Hypertens 2007; 25:671-678.
36. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001; 411:355-365.
37. Miliaras D, Karasavvidou F, Papanikolaou A, Sioutopoulou D. KIT expression in fetal, normal adult, and neoplastic renal tissues. J Clin Pathol 2004; 57:463-466.
38. Dressler GR, Douglass EC. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci USA 1992; 89:1179-1183.
39. Rothenpieler UW, Dressler GR. Pax-2 is required for mesenchyme-to- epithelium conversion during kidney development. Development 1993; 119:711-720.
40. Imgrund M, Grone HJ, Kretzler M, Holzman L, Schlondorff D, Rothernpaler UW. Re-expression of the development gene Pax-2 during experimental acute tubular necrosis in mice. Kidney Int 1999; 56:1423-1431.
41. Cochrane AL, Kett MM, Samuel CS, Campanale NV, Anderson WP, Hume DA, et al. Renal structural and functional repair in a mouse model of reversal of ureteric obstruction. J Am Soc Nephrol 2005; 16:3623-3630.